Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Cerebral Amyloid Angiopathy Related Inflammation With Prominent Meningeal Involvement. A Report of 2 Cases.

Aghetti A, Sène D, Polivka M, Shor N, Lechtman S, Chabriat H, Jouvent E, Guey S.

Front Neurol. 2019 Sep 23;10:984. doi: 10.3389/fneur.2019.00984. eCollection 2019.

PMID:
31608002
2.

Alteration of the Cortex Shape as a Proxy of White Matter Swelling in Severe Cerebral Small Vessel Disease.

De Guio F, Germanaud D, Lefèvre J, Fischer C, Mangin JF, Chabriat H, Jouvent E.

Front Neurol. 2019 Jul 10;10:753. doi: 10.3389/fneur.2019.00753. eCollection 2019.

3.

Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.

Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network.

Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23. Erratum in: Lancet Neurol. 2019 Sep;18(9):e8.

4.

Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.

Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Frayne R, Ikram MA, Jouvent E, MacIntosh BJ, Thrippleton MJ, Vernooij MW, Adams H, Backes WH, Ballerini L, Black SE, Chen C, Corriveau R, DeCarli C, Greenberg SM, Gurol ME, Ingrisch M, Job D, Lam BYK, Launer LJ, Linn J, McCreary CR, Mok VCT, Pantoni L, Pike GB, Ramirez J, Reijmer YD, Romero JR, Ropele S, Rost NS, Sachdev PS, Scott CJM, Seshadri S, Sharma M, Sourbron S, Steketee RME, Swartz RH, van Oostenbrugge R, van Osch M, van Rooden S, Viswanathan A, Werring D, Dichgans M, Wardlaw JM.

Alzheimers Dement (Amst). 2019 Feb 26;11:191-204. doi: 10.1016/j.dadm.2019.01.002. eCollection 2019 Dec. Review.

5.

Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.

Rutten JW, Van Eijsden BJ, Duering M, Jouvent E, Opherk C, Pantoni L, Federico A, Dichgans M, Markus HS, Chabriat H, Oberstein SAJL.

Genet Med. 2019 Aug;21(8):1895. doi: 10.1038/s41436-018-0306-z.

6.

Different Types of White Matter Hyperintensities in CADASIL.

Duchesnay E, Hadj Selem F, De Guio F, Dubois M, Mangin JF, Duering M, Ropele S, Schmidt R, Dichgans M, Chabriat H, Jouvent E.

Front Neurol. 2018 Jul 10;9:526. doi: 10.3389/fneur.2018.00526. eCollection 2018.

7.

The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1-6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7-34 pathogenic variant.

Rutten JW, Van Eijsden BJ, Duering M, Jouvent E, Opherk C, Pantoni L, Federico A, Dichgans M, Markus HS, Chabriat H, Lesnik Oberstein SAJ.

Genet Med. 2019 Mar;21(3):676-682. doi: 10.1038/s41436-018-0088-3. Epub 2018 Jul 22. Erratum in: Genet Med. 2018 Sep 20;:.

8.

Why Are Only Some Subcortical Ischemic Lesions on Diffusion Magnetic Resonance Imaging Associated With Stroke Symptoms in Small Vessel Disease?

Osman O, De Guio F, Chabriat H, Jouvent E.

Stroke. 2018 Aug;49(8):1920-1923. doi: 10.1161/STROKEAHA.118.021342.

PMID:
29986933
9.

Updates on Prevention of Hemorrhagic and Lacunar Strokes.

Tsai HH, Kim JS, Jouvent E, Gurol ME.

J Stroke. 2018 May;20(2):167-179. doi: 10.5853/jos.2018.00787. Epub 2018 May 31.

10.

Validation and Optimization of BIANCA for the Segmentation of Extensive White Matter Hyperintensities.

Ling Y, Jouvent E, Cousyn L, Chabriat H, De Guio F.

Neuroinformatics. 2018 Apr;16(2):269-281. doi: 10.1007/s12021-018-9372-2.

PMID:
29594711
11.

Free water determines diffusion alterations and clinical status in cerebral small vessel disease.

Duering M, Finsterwalder S, Baykara E, Tuladhar AM, Gesierich B, Konieczny MJ, Malik R, Franzmeier N, Ewers M, Jouvent E, Biessels GJ, Schmidt R, de Leeuw FE, Pasternak O, Dichgans M.

Alzheimers Dement. 2018 Jun;14(6):764-774. doi: 10.1016/j.jalz.2017.12.007. Epub 2018 Feb 16.

12.

Clinical correlates of longitudinal MRI changes in CADASIL.

Ling Y, De Guio F, Jouvent E, Duering M, Hervé D, Guichard JP, Godin O, Dichgans M, Chabriat H.

J Cereb Blood Flow Metab. 2019 Jul;39(7):1299-1305. doi: 10.1177/0271678X18757875. Epub 2018 Feb 5.

PMID:
29400120
13.

Reaction Time Is Negatively Associated with Corpus Callosum Area in the Early Stages of CADASIL.

Delorme S, De Guio F, Reyes S, Jabouley A, Chabriat H, Jouvent E.

AJNR Am J Neuroradiol. 2017 Nov;38(11):2094-2099. doi: 10.3174/ajnr.A5378. Epub 2017 Sep 14.

14.

Arterial branching and basal ganglia lacunes: A study in pure small vessel disease.

Moreton FC, Düring M, Phan T, Srikanth V, Beare R, Huang X, Jouvent E, Chabriat H, Dichgans M, Muir KW.

Eur Stroke J. 2017 Sep;2(3):264-271. doi: 10.1177/2396987317718450. Epub 2017 Jul 7.

15.

Cerebral Microbleeds and the Risk of Incident Ischemic Stroke in CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy).

Puy L, De Guio F, Godin O, Duering M, Dichgans M, Chabriat H, Jouvent E.

Stroke. 2017 Oct;48(10):2699-2703. doi: 10.1161/STROKEAHA.117.017839. Epub 2017 Aug 25.

PMID:
28842512
16.

Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.

Donahue MJ, Achten E, Cogswell PM, De Leeuw FE, Derdeyn CP, Dijkhuizen RM, Fan AP, Ghaznawi R, Heit JJ, Ikram MA, Jezzard P, Jordan LC, Jouvent E, Knutsson L, Leigh R, Liebeskind DS, Lin W, Okell TW, Qureshi AI, Stagg CJ, van Osch MJ, van Zijl PC, Watchmaker JM, Wintermark M, Wu O, Zaharchuk G, Zhou J, Hendrikse J.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1391-1417. doi: 10.1177/0271678X17721830. Epub 2017 Aug 17. Review.

17.

Diffusion magnetic resonance imaging in cerebral small vessel disease.

Lyoubi-Idrissi AL, Jouvent E, Poupon C, Chabriat H.

Rev Neurol (Paris). 2017 Apr;173(4):201-210. doi: 10.1016/j.neurol.2017.03.005. Epub 2017 Apr 6. Review.

PMID:
28392060
18.

Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease.

Wollenweber FA, Baykara E, Zedde M, Gesierich B, Achmüller M, Jouvent E, Viswanathan A, Ropele S, Chabriat H, Schmidt R, Opherk C, Dichgans M, Linn J, Duering M.

Stroke. 2017 May;48(5):1404-1407. doi: 10.1161/STROKEAHA.117.016833. Epub 2017 Mar 31.

PMID:
28364025
19.

Focal Macroscopic Cortical Lesions in Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

Lyoubi-Idrissi A, De Guio F, Chabriat H, Jouvent E.

Stroke. 2017 May;48(5):1408-1411. doi: 10.1161/STROKEAHA.116.015724. Epub 2017 Mar 27.

PMID:
28348068
20.

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Di Donato I, Bianchi S, De Stefano N, Dichgans M, Dotti MT, Duering M, Jouvent E, Korczyn AD, Lesnik-Oberstein SA, Malandrini A, Markus HS, Pantoni L, Penco S, Rufa A, Sinanović O, Stojanov D, Federico A.

BMC Med. 2017 Feb 24;15(1):41. doi: 10.1186/s12916-017-0778-8. Review.

21.

Different types of white matter hyperintensities in CADASIL: Insights from 7-Tesla MRI.

De Guio F, Vignaud A, Chabriat H, Jouvent E.

J Cereb Blood Flow Metab. 2018 Sep;38(9):1654-1663. doi: 10.1177/0271678X17690164. Epub 2017 Jan 27.

22.

Predictors and Clinical Impact of Incident Lacunes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

Ling Y, De Guio F, Duering M, Jouvent E, Hervé D, Godin O, Dichgans M, Chabriat H.

Stroke. 2017 Feb;48(2):283-289. doi: 10.1161/STROKEAHA.116.015750. Epub 2016 Dec 29.

PMID:
28034964
23.

Lower Magnetization Transfer Ratio in the Forceps Minor Is Associated with Poorer Gait Velocity in Older Adults.

Seiler S, Pirpamer L, Gesierich B, Hofer E, Duering M, Pinter D, Jouvent E, Fazekas F, Mangin JF, Chabriat H, Ropele S, Schmidt R.

AJNR Am J Neuroradiol. 2017 Mar;38(3):500-506. doi: 10.3174/ajnr.A5036. Epub 2016 Dec 15.

24.

Prediction of 3-year clinical course in CADASIL.

Jouvent E, Duchesnay E, Hadj-Selem F, De Guio F, Mangin JF, Hervé D, Duering M, Ropele S, Schmidt R, Dichgans M, Chabriat H.

Neurology. 2016 Oct 25;87(17):1787-1795. Epub 2016 Sep 30.

25.

A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.

Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, Ropele S, Jouvent E; Alzheimer's Disease Neuroimaging Initiative, Chabriat H, Ertl-Wagner B, Ewers M, Schmidt R, de Leeuw FE, Biessels GJ, Dichgans M, Duering M.

Ann Neurol. 2016 Oct;80(4):581-92. doi: 10.1002/ana.24758. Epub 2016 Aug 29.

PMID:
27518166
26.

Cerebral Microhemorrhages: Significance, Associations, Diagnosis, and Treatment.

Jouvent E, Puy L, Chabriat H.

Curr Treat Options Neurol. 2016 Aug;18(8):35. doi: 10.1007/s11940-016-0418-1. Review.

PMID:
27314427
27.

Determinants of iron accumulation in the normal aging brain.

Pirpamer L, Hofer E, Gesierich B, De Guio F, Freudenberger P, Seiler S, Duering M, Jouvent E, Duchesnay E, Dichgans M, Ropele S, Schmidt R.

Neurobiol Aging. 2016 Jul;43:149-55. doi: 10.1016/j.neurobiolaging.2016.04.002. Epub 2016 Apr 13.

PMID:
27255824
28.

Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.

De Guio F, Jouvent E, Biessels GJ, Black SE, Brayne C, Chen C, Cordonnier C, De Leeuw FE, Dichgans M, Doubal F, Duering M, Dufouil C, Duzel E, Fazekas F, Hachinski V, Ikram MA, Linn J, Matthews PM, Mazoyer B, Mok V, Norrving B, O'Brien JT, Pantoni L, Ropele S, Sachdev P, Schmidt R, Seshadri S, Smith EE, Sposato LA, Stephan B, Swartz RH, Tzourio C, van Buchem M, van der Lugt A, van Oostenbrugge R, Vernooij MW, Viswanathan A, Werring D, Wollenweber F, Wardlaw JM, Chabriat H.

J Cereb Blood Flow Metab. 2016 Aug;36(8):1319-37. doi: 10.1177/0271678X16647396. Epub 2016 May 11. Review.

29.

Features and Determinants of Lacune Shape: Relationship With Fiber Tracts and Perforating Arteries.

Gesierich B, Duchesnay E, Jouvent E, Chabriat H, Schmidt R, Mangin JF, Duering M, Dichgans M.

Stroke. 2016 May;47(5):1258-64. doi: 10.1161/STROKEAHA.116.012779. Epub 2016 Apr 5.

PMID:
27048698
30.

Shape of the Central Sulcus and Disability After Subcortical Stroke: A Motor Reserve Hypothesis.

Jouvent E, Sun ZY, De Guio F, Duchesnay E, Duering M, Ropele S, Dichgans M, Mangin JF, Chabriat H.

Stroke. 2016 Apr;47(4):1023-9. doi: 10.1161/STROKEAHA.115.012562. Epub 2016 Mar 3.

PMID:
26941259
31.

Alterations of the cerebral cortex in sporadic small vessel disease: A systematic review of in vivo MRI data.

Peres R, De Guio F, Chabriat H, Jouvent E.

J Cereb Blood Flow Metab. 2016 Apr;36(4):681-95. doi: 10.1177/0271678X15625352. Epub 2016 Jan 19. Review.

32.

Prevalence and characteristics of migraine in CADASIL.

Guey S, Mawet J, Hervé D, Duering M, Godin O, Jouvent E, Opherk C, Alili N, Dichgans M, Chabriat H.

Cephalalgia. 2016 Oct;36(11):1038-1047. doi: 10.1177/0333102415620909. Epub 2016 Jul 11.

PMID:
26646784
33.

Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.

Chabriat H, Hervé D, Duering M, Godin O, Jouvent E, Opherk C, Alili N, Reyes S, Jabouley A, Zieren N, Guichard JP, Pachai C, Vicaut E, Dichgans M.

Stroke. 2016 Jan;47(1):4-11. doi: 10.1161/STROKEAHA.115.010696. Epub 2015 Nov 17.

PMID:
26578659
34.

Reaction Time is a Marker of Early Cognitive and Behavioral Alterations in Pure Cerebral Small Vessel Disease.

Jouvent E, Reyes S, De Guio F, Chabriat H.

J Alzheimers Dis. 2015;47(2):413-9. doi: 10.3233/JAD-150083.

PMID:
26401563
35.

APOE ɛ2 is associated with white matter hyperintensity volume in CADASIL.

Gesierich B, Opherk C, Rosand J, Gonik M, Malik R, Jouvent E, Hervé D, Adib-Samii P, Bevan S, Pianese L, Silvestri S, Dotti MT, De Stefano N, van der Grond J, Boon EM, Pescini F, Rost N, Pantoni L, Oberstein SA, Federico A, Ragno M, Markus HS, Tournier-Lasserve E, Chabriat H, Dichgans M, Duering M, Ewers M.

J Cereb Blood Flow Metab. 2016 Jan;36(1):199-203.

36.

R2* mapping for brain iron: associations with cognition in normal aging.

Ghadery C, Pirpamer L, Hofer E, Langkammer C, Petrovic K, Loitfelder M, Schwingenschuh P, Seiler S, Duering M, Jouvent E, Schmidt H, Fazekas F, Mangin JF, Chabriat H, Dichgans M, Ropele S, Schmidt R.

Neurobiol Aging. 2015 Feb;36(2):925-32. doi: 10.1016/j.neurobiolaging.2014.09.013. Epub 2014 Sep 19.

PMID:
25443291
37.

White matter edema at the early stage of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

De Guio F, Mangin JF, Duering M, Ropele S, Chabriat H, Jouvent E.

Stroke. 2015 Jan;46(1):258-61. doi: 10.1161/STROKEAHA.114.007018. Epub 2014 Nov 4.

PMID:
25370582
38.

Magnetization transfer ratio relates to cognitive impairment in normal elderly.

Seiler S, Pirpamer L, Hofer E, Duering M, Jouvent E, Fazekas F, Mangin JF, Chabriat H, Dichgans M, Ropele S, Schmidt R.

Front Aging Neurosci. 2014 Sep 25;6:263. doi: 10.3389/fnagi.2014.00263. eCollection 2014.

39.

In vivo high-resolution 7 Tesla MRI shows early and diffuse cortical alterations in CADASIL.

De Guio F, Reyes S, Vignaud A, Duering M, Ropele S, Duchesnay E, Chabriat H, Jouvent E.

PLoS One. 2014 Aug 28;9(8):e106311. doi: 10.1371/journal.pone.0106311. eCollection 2014.

40.

Loss of venous integrity in cerebral small vessel disease: a 7-T MRI study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

De Guio F, Vignaud A, Ropele S, Duering M, Duchesnay E, Chabriat H, Jouvent E.

Stroke. 2014 Jul;45(7):2124-6. doi: 10.1161/STROKEAHA.114.005726. Epub 2014 May 27.

PMID:
24867926
41.

ADC histograms from routine DWI for longitudinal studies in cerebral small vessel disease: a field study in CADASIL.

Gunda B, Porcher R, Duering M, Guichard JP, Mawet J, Jouvent E, Dichgans M, Chabriat H.

PLoS One. 2014 May 12;9(5):e97173. doi: 10.1371/journal.pone.0097173. eCollection 2014.

42.

Strategic white matter tracts for processing speed deficits in age-related small vessel disease.

Duering M, Gesierich B, Seiler S, Pirpamer L, Gonik M, Hofer E, Jouvent E, Duchesnay E, Chabriat H, Ropele S, Schmidt R, Dichgans M.

Neurology. 2014 Jun 3;82(22):1946-50. doi: 10.1212/WNL.0000000000000475. Epub 2014 May 2.

43.

Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL.

Opherk C, Gonik M, Duering M, Malik R, Jouvent E, Hervé D, Adib-Samii P, Bevan S, Pianese L, Silvestri S, Dotti MT, De Stefano N, Liem M, Boon EM, Pescini F, Pachai C, Bracoud L, Müller-Myhsok B, Meitinger T, Rost N, Pantoni L, Lesnik Oberstein S, Federico A, Ragno M, Markus HS, Tournier-Lasserve E, Rosand J, Chabriat H, Dichgans M.

Stroke. 2014 Apr;45(4):968-72. doi: 10.1161/STROKEAHA.113.004461. Epub 2014 Feb 27.

PMID:
24578207
44.

Dilated perivascular spaces in small-vessel disease: a study in CADASIL.

Yao M, Hervé D, Jouvent E, Duering M, Reyes S, Godin O, Guichard JP, Dichgans M, Chabriat H.

Cerebrovasc Dis. 2014;37(3):155-63. doi: 10.1159/000356982. Epub 2014 Feb 5.

PMID:
24503815
45.

Impact of regional cortical and subcortical changes on processing speed in cerebral small vessel disease.

Righart R, Duering M, Gonik M, Jouvent E, Reyes S, Hervé D, Chabriat H, Dichgans M.

Neuroimage Clin. 2013 Jun 19;2:854-61. doi: 10.1016/j.nicl.2013.06.006. eCollection 2013.

46.

Pure psychiatric presentation of Fragile X-associated tremor/ataxia syndrome.

Reiner P, Taifas I, Massiou H, Jouvent E.

Eur J Neurol. 2013 Sep;20(9):e113-4. doi: 10.1111/ene.12206. No abstract available.

PMID:
23889896
47.

Decreased T1 contrast between gray matter and normal-appearing white matter in CADASIL.

De Guio F, Reyes S, Duering M, Pirpamer L, Chabriat H, Jouvent E.

AJNR Am J Neuroradiol. 2014 Jan;35(1):72-6. doi: 10.3174/ajnr.A3639. Epub 2013 Jul 18.

48.

Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease.

Duering M, Csanadi E, Gesierich B, Jouvent E, Hervé D, Seiler S, Belaroussi B, Ropele S, Schmidt R, Chabriat H, Dichgans M.

Brain. 2013 Sep;136(Pt 9):2717-26. doi: 10.1093/brain/awt184. Epub 2013 Jul 17.

PMID:
23864274
49.

Neurological presentation of schistosomiasis.

Szekeres C, Galletout P, Jaureguiberry S, Crickx E, Monsel G, Chabriat H, Jouvent E.

Lancet. 2013 May 18;381(9879):1788. doi: 10.1016/S0140-6736(13)60317-7. No abstract available.

PMID:
23683646
50.

[Stroke diagnosis and management].

Reiner P, Jouvent E, Chabriat H.

Rev Prat. 2013 Apr;63(4):565-72. French. No abstract available.

PMID:
23682493

Supplemental Content

Loading ...
Support Center